|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 150.1 EUR | -1.48% |
|
+2.28% | +4.16% |
| Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
| Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
FRANKFURT (Reuters) - Merck will start offering non-prescription drugs in China as part of a push to double revenues in the region to 1 billion euros ($1.3 billion) by 2018, Chief Executive Karl-Ludwig Kley told German weekly Wirtschaftswoche.
Merck will focus on treatments related to diabetes, thyroid issues and heart problems, and supply medication made at a new factory in Nantong which is due to start production in 2017, Wirtschaftswoche said.
($1 = 0.7447 Euros)
(Reporting by Edward Taylor; Editing by Ruth Pitchford)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 130.7 USD | +2.93% | +4.38% | 322B | ||
| 12.45 EUR | -0.32% | +1.55% | 34.86B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +4.16% | 70.78B | |
| +10.72% | 9.15B | |
| -17.03% | 4.84B | |
| +37.51% | 4.22B | |
| +3.92% | 3.92B | |
| +18.14% | 2.55B | |
| -24.13% | 2.26B | |
| -29.70% | 2.24B | |
| +9.09% | 1.92B | |
| +1.28% | 1.66B |
MERCK KGAA 
